Global Cell Cytometry Market (Focus on High Throughput Flow Cytometers and Image Cytometers) Distribution by Type of Cytometer (High Throughput Flow Cytometers and Image Cytometers), Company Size (Very Small, Small, Mid-sized, Large, and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    January 2023

  • Pages
    195

  • View Count
    972

Example Insights

Global-Cell-Cytometry-Market-Context-thumb Global-Cell-Cytometry-Market-Cell-Cytometers-thumb Global-Cell-Cytometry-Market-Color-Channels-thumb
Global-Cell-Cytometry-Market-Competitiveness-Analysis-thumb Global-Cell-Cytometry-Market-Collaborations-thumb Global-Cell-Cytometry-Market-Investments-thumb
Global-Cell-Cytometry-Market-Global-Events-thumb Global-Cell-Cytometry-Market-Patent-Analysis-thumb Global-Cell-Cytometry-Market-Cytometry-Market-thumb

Overview

Novel cell cytometry devices have recently emerged as crucial analytical and visualization tools that have revolutionized the global cell cytometry industry. These technologically driven tools are used for multiple purposes in the research industry, such as identification and analysis of cells in a biological sample, cell characterization, cell sorting, cell cycle analyses, cell proliferation assays, immunophenotyping and hematological studies.

Q1. What are the limitations of conventional cell cytometers?

The key concerns related to traditional cell cytometers include long turnover rates and poor visualization of analysis output. In addition, the conventional systems are incapable of handling large sample size and lack data processing software.

Q2. What are the different types of novel cell cytometers? What are the key advantages offered by novel cell cytometers?

In order to overcome the challenges of conventional cell cytometers, several medical device companies have developed technologically advanced variants of cell cytometers, including flow cytometers, facs flow cytometers, image cytometers, and time lapse cytometers. These novel devices offer various advantages; for instance, the high throughput flow cytometers have the ability to rapidly analyze large libraries of cells at once and allow the measurement of various characteristics of a sample. On the other hand, image cytometers are designed to visualize the cells and analyze multiple parameters of the sample using various proprietary features, such as spectral absorbance, multiple fluorescence channels, brightfield microscopy and luminescence at a greater speed.

Q3. What is the current market landscape of global high throughput flow cytometers and image cytometers market?

Presently, more than 180 high throughput flow / image cytometers that offer improved turnaround time and ease of operability are available in the market to streamline analytical workflows. It is worth highlighting that several novel cell cytometer developers have entered into strategic alliances in order to enhance their existing product capabilities and consolidate their presence in this domain. Additionally, close to 80% of the global events in this industry have been organized, since 2020. Several patents related to high throughput flow cytometers and image cytometers have been recently filed / granted, demonstrating the continuous innovation in this domain.

Q4. What are the key value drivers in the global cell cytometry market, focusing on high throughput flow cytometers and image cytometers?

In the recent years, the global cell cytometry market has witnessed an increase in the demand for advanced cell analyzers that are capable of not only counting / sorting the cells but also offer assessment of cell functions / characteristics in addition to the identification of potential biomarkers. Additionally, the adoption of high throughput flow cytometers and image cytometers in novel research application areas, including proteomics, cytogenomics and oncology research, has further contributed to the growth of this market.  

Q5. What is the current / future market size of global cell cytometry market, focusing on high throughput flow cytometers and image cytometers? Which segments of this market are anticipated to capture the major share?

The global cell cytometry market, focusing on high through flow cytometers and image cytometers, is projected to grow at a CAGR of 8.6% in the coming years. Currently, in terms of type of cytometer, the market is captured by high throughput cell cytometers. However, this trend is expected to change in the foreseen future as the demand for image cytometers is anticipated to increase in the next 8 years. Specifically, in terms of geography, the market in North America is likely to grow at a relatively faster pace in the long term. 

Q6. Who are the key players engaged in the global cell cytometry market, focusing on high through flow cytometers and image cytometers?

Examples of key players engaged in this domain (which have also been captured in this report) include Agilent, Beckton Dickinson, Beckman Coulter Life Sciences, Bio-Rad, Chemometec, Milkotronic, Nexcelom Bioscience, Sartorius, Sony Biotechnology, ThermoFisher Scientific and Union Biometrica.

Scope of the Report

The “Global Cell Cytometry Market, Focus on High Throughput Flow Cytometers and Image Cytometers by Type of Cytometer (High Throughput Flow Cytometers and Image Cytometers), Company Size (Very Small, Small, Mid-sized, Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the current market landscape and future potential of high throughput flow cytometers and image cytometers, over the next decade. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. In addition to other elements, the report includes:

  • A general overview of cell cytometry, featuring information on the different types of cytometry, namely high throughput flow cytometry and image cytometry, along with details on their advantages and limitations. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years.
  • A detailed assessment of the market landscape of high throughput flow cytometers based on several relevant parameters, such as type of high throughput flow cytometer, throughput rate (wells per minute), detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions (W×D×H), sample volume (in µl), type of detection mechanism(s), and application(s). In addition, the chapter includes analysis of high throughput flow cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products offered).
  • An insightful product competitiveness analysis of high throughput flow cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of high throughput flow cytometer, throughput rate, detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions, sample volume (in µl), type of detection mechanism(s) and application(s)). 
  • A detailed assessment of the market landscape of image cytometers based on several relevant parameters, such as type of image cytometer, processing time, type of plate format, output format, sample volume, product dimensions (W×D×H) and application(s). In addition, the chapter includes analysis of image cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products being offered).
  • An insightful product competitiveness analysis of image cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of image cytometer, processing time, output format, average sample volume and application(s)). 
  • Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in the development / commercialization of cell cytometers (high throughput flow cytometers and image cytometers). Each profile features a brief overview of the company, recent developments and an informed future outlook. 
  • An insightful analysis of the partnerships that have been inked within the global cell cytometry industry since 2017, based on several relevant parameters, such as year of partnership, type of partnership (acquisitions, asset acquisitions, commercialization agreements, commercialization and distribution agreements, distribution agreements,  product development agreements storage and distribution agreements and others), most active players (in terms of number of deals inked) and regional distribution of partnership activity. 
  • An analysis of various recent developments / trends related to global cell cytometry domain, offering insights on the funding activity in this domain, based on several relevant parameters, such as year of funding, type of funding, amount invested (USD Million), most active players (in terms of number of instances and amount raised), and most active investors (in terms of number of instances). In addition, it provides information on the analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, event platform, type of event, most active organizers (in terms of number of events) and most active organizations (in terms of number of participants).
  • An insightful analysis of the patents filed / granted for cell cytometry, since 2020, taking into consideration various relevant parameters, such as type of patent, publication year, annual number of granted patents and patent applications, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.

One of the key objectives of the report was to estimate the existing market size and the future opportunity for cell cytometry, over the coming 13 years. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of cytometer (high throughput flow cytometers and image cytometers), company size (very small, small, mid-sized, large, and very large) and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the anticipated industry’s growth. The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. 
 
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

  • Which are the popular types of cytometers available in the market?
  • What are the high througput cell cytometer technologies? 
  • Who are the leading players engaged in the development of high throughput flow cytometers and image cytometers?
  • What are the common partnership models in global cell cytometer market?
  • What are the investment trends in the global cell cytometry industry?
  • Who are the key investors that are active in the development and commercialization of cell cytometers?
  • What are the key agenda items being discussed in various global events / conferences that are related to cell cytometry?
  • What is the global patent landscape of cell cytometery market?
  • What will be the total market value of the global cell cytometry market in 2035?
  • Which key geographical region of the global cell cytometry market is expected to witness the highest growth?

Contents

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Cell Cytometry
3.2.1. Flow Cytometry
3.2.1.1. High Throughput Flow Cytometry

3.2.2 Image Cytometry

3.3. Advantages and Limitations of Cell Cytometry
3.4. Prevalent Trends Related to Cell Cytometry
3.4.1. Key Historical Trends
3.4.2. Emerging Focus Area
3.4.3. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. High Throughput Flow Cytometers: Overall Market Landscape
4.2.1. Analysis by Type of High Throughput Flow Cytometer
4.2.2. Analysis by Throughput Rate
4.2.3. Analysis by Detection Rate
4.2.4. Analysis by Type of Plate Format
4.2.5. Analysis by Number of Color Channels
4.2.6. Analysis by Number of Detection Channels
4.2.7. Analysis by Number of Laser Channels
4.2.8. Analysis by Product Dimensions
4.2.9. Analysis by Sample Volume
4.2.10. Analysis by Type of Detection Mechanism
4.2.11 Analysis by Application(s)

4.3. High Throughput Flow Cytometers: Developer Landscape
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3 Analysis by Location of Headquarters
4.3.4 Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis
5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in North America
5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in Europe and Asia

6. IMAGE CYTOMETERS: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Image Cytometers: Overall Market Landscape
6.2.1. Analysis by Type of Image Cytometer
6.2.2. Analysis by Processing Time
6.2.3. Analysis by Type of Plate Format
6.2.4. Analysis by Output Format
6.2.5. Analysis by Sample Volume
6.2.6. Analysis by Product Dimensions
6.2.7. Analysis by Application(s)

6.3. Image Cytometers: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS
7.1. Chapter Overview
7.2. Assumptions / Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis
7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America
7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES
8.1. Chapter Overview
8.2. Agilent
8.2.1. Company Overview
8.2.2. Recent Developments and Future Outlook

8.3. Beckman Coulter Life Sciences
8.3.1. Company Overview
8.3.2. Recent Developments and Future Outlook

8.4. Becton Dickinson
8.4.1. Company Overview
8.4.2. Recent Developments and Future Outlook

8.5. Bio-Rad
8.5.1. Company Overview
8.5.2. Recent Developments and Future Outlook

8.6. Chemometec
8.6.1. Company Overview
8.6.2. Recent Developments and Future Outlook

8.7. Milkotronic
8.7.1. Company Overview
8.7.2. Recent Developments and Future Outlook

8.8. Nexcelom Bioscience
8.8.1. Company Overview
8.8.2. Recent Developments and Future Outlook

8.9. Sartorius
8.9.1. Company Overview
8.9.2. Recent Developments and Future Outlook

8.10. Sony Biotechnology
8.10.1. Company Overview
8.10.2. Recent Developments and Future Outlook

8.11. ThermoFisher Scientific
8.11.1. Company Overview
8.11.2. Recent Developments and Future Outlook

8.12. Union Biometrica
8.12.1. Company Overview
8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Most Active Players: Analysis by Number of Partnerships
9.3.4. Regional Analysis
9.3.5. Intercontinental and Intracontinental Agreements

10. RECENT DEVELOPMENTS
10.1. Chapter Overview
10.2. Global Cell Cytometry: Funding and Investment Analysis
10.2.1. Types of Funding
10.2.2. List of Funding and Investments
10.2.3. Analysis by Year of Investment
10.2.4. Analysis by Type of Funding
10.2.5. Analysis by Amount Invested
10.2.6. Most Active Players: Analysis by Number of Funding Instances
10.2.7. Most Active Players: Analysis by Amount Raised
10.2.8. Most Active Investors: Analysis by Number of Funding Instances

10.3. Global Cell Cytometry: Global Event Analysis
10.3.1. List of Global Events
10.3.1.1. Analysis by Year of Event
10.3.1.2. Analysis by Event Platform
10.3.1.3. Analysis by Type of Events
10.3.1.4. Analysis by Geography
10.3.1.5. Most Active Event Organizers: Analysis by Number of Events
10.3.1.6. Most Active Organizations: Analysis by Number of Participants

10.4. Concluding Remarks

11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.2.1. Analysis by Type of Patent
11.2.2. Analysis by Patent Publication Year
11.2.3. Analysis by Annual Number of Granted Patents and Patent Applications
11.2.4. Analysis by Geographical Location
11.2.5. Analysis by CPC Symbols
11.2.6. Word Cloud: Emerging Focus Areas
11.2.7. Analysis by Type of Organization
11.2.8. Leading Industry Players: Analysis by Number of Patents
11.2.9. Leading Non-Industry Players: Analysis by Number of Patents

11.3. Cell Cytometry: Patent Benchmarking Analysis
11.3.1. Analysis by Patent Characteristics

11.4. Cell Cytometry: Patent Valuation Analysis
11.5. Leading Patents by Number of Citations

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Cytometry Market, 2022-2035
12.3.1 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer, 2022 and 2035
12.3.1.1. Cell Cytometry Market for High Throughput Flow Cytometers, 2022-2035
12.3.1.2. Cell Cytometry Market for Image Cytometers, 2022-2035

12.3.2. Global Cell Cytometry Market: Distribution by Company Size, 2022 and 2035
12.3.2.1. Cell Cytometry Market for Very Small Companies, 2022-2035
12.3.2.2. Cell Cytometry Market for Small Companies, 2022-2035
12.3.2.3. Cell Cytometry Market for Mid-sized Companies, 2022-2035
12.3.2.4. Cell Cytometry Market for Large Companies, 2022-2035
12.3.2.5. Cell Cytometry Market for Very Large Companies, 2022-2035

12.3.3. Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
12.3.3.1. Cell Cytometry Market in North America, 2022-2035
12.3.3.2. Cell Cytometry Market in Europe, 2022-2035
12.3.3.3. Cell Cytometry Market in Asia, 2022-2035
12.3.3.4. Cell Cytometry Market in Rest of the World, 2022-2035

13 CONCLUDING REMARKS

14 EXECUTIVE INSIGHTS

15 APPENDIX 1: TABULATED DATA

16 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: High Throughput Flow Cytometers Market Landscape
Figure 2.2 Executive Summary: Image Cytometers Market Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Funding and Investment Analysis
Figure 2.5 Executive Summary: Global Events
Figure 2.6 Executive Summary: Patent Analysis
Figure 2.7 Executive Summary: Market Forecast
Figure 3.1 Types of Cytometers
Figure 3.2 Advantages of Different Types of Cytometry
Figure 3.3 Limitations of Different Types of Cytometry
Figure 4.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
Figure 4.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
Figure 4.3 High Throughput Flow Cytometers: Distribution by Detection Rate
Figure 4.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format
Figure 4.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
Figure 4.6 High Throughput Flow Cytometers: Distribution by Number of Detection Channels
Figure 4.7 High Throughput Flow Cytometers: Distribution by Number of Laser Channels
Figure 4.8 High Throughput Flow Cytometers: Distribution by Product Dimensions
Figure 4.9 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
Figure 4.10 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism
Figure 4.11 High Throughput Flow Cytometers: Distribution by Application(s)
Figure 4.12 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
Figure 4.13 High Throughput Flow Cytometer Developers: Distribution by Company Size
Figure 4.14 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
Figure 4.15 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
Figure 5.1 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in North America
Figure 5.2 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in Europe and Asia-Pacific
Figure 6.1 Image Cytometer: Distribution by Type of Image Cytometer
Figure 6.2 Image Cytometer: Distribution by Processing Time
Figure 6.3 Image Cytometer: Distribution by Type of Plate Format
Figure 6.4 Image Cytometers: Distribution by Output Format
Figure 6.5 Image Cytometers: Distribution by Sample Volume
Figure 6.6 Image Cytometer: Distribution by Product Dimensions
Figure 6.7 Image Cytometer: Distribution by Application(s)
Figure 6.8 Image Cytometer Developers: Distribution by Year of Establishment
Figure 6.9 Image Cytometer Developers: Distribution by Company Size
Figure 6.10 Image Cytometer Developers: Distribution by Location of Headquarters
Figure 6.11 Leading Image Cytometer Developers: Distribution by Number of Products Offered
Figure 7.1 Product Competitiveness Analysis: Image Cytometers offered by Players based in North America
Figure 7.2 Product Competitiveness Analysis: Image Cytometers offered by Players based in Europe and Asia-Pacific
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Figure 9.4 Most Active Players: Distribution by Number of Partnerships
Figure 9.5 Partnerships and Collaborations: Regional Analysis
Figure 9.6 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
Figure 10.2 Funding and Investment Analysis: Distribution by Type of Funding
Figure 10.3 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, 2017-2022 (USD Million)
Figure 10.4 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.5 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, 2017-2022 (USD Million)
Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
Figure 10.7 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.8 Most Active Investors: Distribution by Number of Funding Instances
Figure 10.9 Global Events: Cumulative Half yearly Trend, 2018 - H2 2022
Figure 10.10 Global Events: Distribution by Event Platform
Figure 10.11 Global Events: Distribution by Type of Event
Figure 10.12 Global Events: Regional Distribution of Events
Figure 10.13 Most Active Event Organizers: Distribution by Number of Events
Figure 10.14 Most Active Organizations: Distribution by Number of Participants
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, 2020-2022
Figure 11.3 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, 2020-2022
Figure 11.4 Patent Analysis: Distribution by Geographical Location
Figure 11.5 Patent Analysis: Distribution by CPC Symbols
Figure 11.6 Word Cloud: Emerging Focus Areas
Figure 11.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2020-2022
Figure 11.8 Leading Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.10 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.11 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 11.12 Patent Analysis: Year-wise Distribution of Patents by Age
Figure 11.13 Cell Cytometry: Patent Valuation Analysis
Figure 12.1 Global Cell Cytometry Market, 2022-2035 (USD Million)
Figure 12.2 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer, 2022 and 2035
Figure 12.3 Cell Cytometry Market for High Throughput Flow Cytometers, 2022- 2035 (USD Million)
Figure 12.4 Cell Cytometry Market for Image Cytometers, 2022-2035 (USD Million)
Figure 12.5 Global Cell Cytometry Market: Distribution by Company Size, 2022 and 2035
Figure 12.6 Cell Cytometry Market for Very Small Companies, 2022-2035 (USD Million)
Figure 12.7 Cell Cytometry Market for Small Companies, 2022-2035 (USD Million)
Figure 12.8 Cell Cytometry Market for Mid-sized Companies, 2022-2035 (USD Million)
Figure 12.9 Cell Cytometry Market for Large Companies, 2022-2035 (USD Million)
Figure 12.10 Cell Cytometry Market for Very Large Companies, 2022-2035 (USD Million)
Figure 12.11 Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
Figure 12.12 Cell Cytometry Market in North America, 2022-2035 (USD Million)
Figure 12.13 Cell Cytometry Market in Europe, 2022-2035 (USD Million)
Figure 12.14 Cell Cytometry Market in Asia, 2022-2035 (USD Million)
Figure 12.15 Cell Cytometry Market in Rest of the World, 2022-2035 (USD Million)
Figure 13.1 Concluding Remarks: High Throughput Flow Cytometers Market Landscape
Figure 13.2 Concluding Remarks: Image Cytometers Market Landscape
Figure 13.3 Concluding Remarks: Partnerships and Collaborations
Figure 13.4 Concluding Remarks: Funding and Investment Analysis
Figure 13.5 Concluding Remarks: Global Events
Figure 13.6 Concluding Remarks: Patent Analysis
Figure 13.7 Concluding Remarks: Market Forecast

List Of Tables

Table 4.1 High Throughput Flow Cytometers: Information on Type of High Throughput Flow Cytometer and Throughput Rate
Table 4.2 High Throughput Flow Cytometers: Information on Detection Rate
Table 4.3 High Throughput Flow Cytometers: Information on Type of Plate Format
Table 4.4 High Throughput Flow Cytometers: Information on Type of Color Channel
Table 4.5 High Throughput Flow Cytometers: Information on Type of Detection Channel
Table 4.6 High Throughput Flow Cytometers: Information on Type of Laser Channel, Product Dimensions and Patented Technology
Table 4.7 High Throughput Flow Cytometers: Information on Automation Availability, Availability of Automatic Sampling and Sample Volume
Table 4.8 High Throughput Flow Cytometers: Information on Type of Detection Mechanism
Table 4.9 High Throughput Flow Cytometers: Information on Application(s)
Table 4.10 High Throughput Flow Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.1 Image Cytometer: Information on Type of Image Cytometer
Table 6.2 Image Cytometers: Information on Processing Time
Table 6.3 Image Cytometer: Information on Type of Plate Format and Magnification
Table 6.4 Image Cytometer: Information on Output Format
Table 6.5 Image Cytometer: Information on Sample Volume and Product Dimensions
Table 6.6 Image Cytometers: Information on Application(s)
Table 6.7 Image Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 8.1 List of Companies Profiled
Table 8.2 Agilent: Company Overview
Table 8.3 Agilent: Recent Developments and Future Outlook
Table 8.4 Beckman Coulter Life Sciences: Company Overview
Table 8.5 Beckman Coulter Life Sciences: Recent Developments and Future Outlook
Table 8.6 Becton Dickinson: Company Overview
Table 8.7 Becton Dickinson: Recent Developments and Future Outlook
Table 8.8 Bio-Rad: Company Overview
Table 8.9 Bio-Rad: Recent Developments and Future Outlook
Table 8.10 Chemometec: Company Overview
Table 8.11 Chemotec: Recent Developments and Future Outlook
Table 8.12 Easycounter: Company Overview
Table 8.13 Nexcelom Bioscinces: Company Overview
Table 8.14 Sartorius: Company Overview
Table 8.15 Sartorius: Recent Developments and Future Outlook
Table 8.16 Sony Biotechnology: Company Overview
Table 8.17 Thermo Fischer Scientific: Company Overview
Table 8.18 Thermo Fischer Scientific: Recent Developments and Future Outlook
Table 8.19 Union Biometrica: Company Overview
Table 8.20 Union Biometrica: Recent Developments and Future Outlook
Table 9.1 Global Cell Cytometry: List of Partnerships and Collaborations, 2017-2022
Table 10.1 Global Cell Cytometry: List of Funding and Investments, 2017-2022
Table 10.2 Global Cell Cytometry: List of Global Events, 2018- 2022
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: List of Top CPC Symbols
Table 11.3 Patent Analysis: Most Popular CPC Symbols
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 15.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
Table 15.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
Table 15.3 High Throughput Flow Cytometers: Distribution by Detection Rate
Table 15.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format
Table 15.5 High Throughput Flow Cytometers: Distribution by Type of Color Channel
Table 15.6 High Throughput Flow Cytometers: Distribution by Type of Detection Channel
Table 15.7 High Throughput Flow Cytometers: Distribution by Type of Laser Channel
Table 15.8 High Throughput Flow Cytometers: Distribution by Product Dimensions
Table 15.9 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
Table 15.10 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism
Table 15.11 High Throughput Flow Cytometers: Distribution by Application(s)
Table 15.12 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
Table 15.13 High Throughput Flow Cytometer Developers: Distribution by Company Size
Table 15.14 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters
Table 15.15 Number of Products Offered Leading High Throughput Flow Cytometer Developers: Distribution by
Table 15.16 Image Cytometers: Distribution by Type of Image Cytometer
Table 15.17 Image Cytometers: Distribution by Processing Time
Table 15.18 Image Cytometers: Distribution by Type of Plate Format
Table 15.19 Image Cytometers: Distribution by Output Format
Table 15.20 Image Cytometers: Distribution by Sample Volume
Table 15.21 Image Cytometers: Distribution by Product Dimensions
Table 15.22 Image Cytometers: Distribution by Application(s)
Table 15.23 Image Cytometer Developers: Distribution by Year of Establishment
Table 15.24 Image Cytometer Developers: Distribution by Company Size
Table 15.25 Image Cytometer Developers: Distribution by Location of Headquarters
Table 15.26 Leading Image Cytometer Developers: Distribution by Number of Products Offered
Table 15.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Table 15.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.29 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Table 15.30 Most Active Players: Distribution by Number of Partnerships
Table 15.31 Partnerships and Collaborations: Regional Analysis
Table 15.32 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.33 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
Table 15.34 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.35 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, 2017-2022 (USD Million)
Table 15.36 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.37 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, 2017-2022 (USD Million)
Table 15.38 Most Active Players: Distribution by Number of Funding Instances
Table 15.39 Most Active Players: Distribution by Amount Raised (USD Million)
Table 15.40 Most Active Investors: Distribution by Number of Funding Instances
Table 15.41 Global Events: Cumulative Half yearly Trend, 2018 - H2 2022
Table 15.42 Global Events: Distribution by Event Platform
Table 15.43 Global Events: Distribution by Type of Event
Table 15.44 Global Events: Regional Distribution of Event
Table 15.45 Most Active Event Organizers: Distribution by Number of Events
Table 15.46 Most Active Organizations: Distribution by Number of Participants
Table 15.47 Patent Analysis: Distribution by Type of Patent
Table 15.48 Patent Analysis: Cumulative Distribution by Publication Year, 2020-2022
Table 15.49 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, 2020-2022
Table 15.50 Patent Analysis: Distribution by Geographical Location
Table 15.51 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2020-2022
Table 15.52 Leading Industry Players: Distribution by Number of Patents
Table 15.53 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.54 Leading Individual Assignees: Distribution by Number of Patents
Table 15.55 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Table 15.56 Patent Analysis: Year-wise Distribution of Patents by Age
Table 15.57 Cell Cytometry: Patent Valuation Analysis
Table 15.58 Global Cell Cytometry Market, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.59 Global Cell Cytometry Market: Distribution by Type of Cytometer, 2022 and 2035
Table 15.60 Cell Cytometry Market for High Throughput Flow Cytometers, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.61 Cell Cytometry Market for Image Cytometers, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.62 Global Cell Cytometry Market: Distribution by Company Size, 2022 and2035
Table 15.63 Cell Cytometry Market for Very Small Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.64 Cell Cytometry Market for Small Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.65 Cell Cytometry Market for Mid-Sized Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.66 Cell Cytometry Market for Large Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.67 Cell Cytometry Market for Very Large Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.68 Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
Table 15.69 Cell Cytometry Market in North America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.70 Cell Cytometry Market in Europe, 2022-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.71 Cell Cytometry Market in Asia-Pacific, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.72 Cell Cytometry Market in Rest of the World, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. 3E Bioventures
  2. 5 Prime Ventures
  3. Abacus dx
  4. Accellix
  5. ACEA Biosciences (acquired by Agilent)
  6. Agilent
  7. Ampersand Capital Partners
  8. Anzu Partners
  9. Beckman Coulter Life Sciences (acquired by Danaher)
  10. Becton Dickinson
  11. BennuBio
  12. BioLegend (a subsidiary of PerkinElmer)
  13. bioMérieux
  14. Bionovation Biotech
  15. Bioscribe
  16. Bio-Rad Laboratories
  17. Casdin Capital
  18. Chemometec
  19. Cottonwood Technology Fund
  20. Co-Win Ventures
  21. Cyberfreight Pharma Logistics
  22. Cytek Biosciences
  23. Cytobank
  24. Cytognos (acquired by Becton Dickinson)
  25. De Novo Software
  26. Diethelm Keller Siber Hegner (DKSH)
  27. Easy Prosperity
  28. Eight Roads Ventures
  29. FlowJo
  30. F-Prime Capital
  31. FusionX Ventures
  32. GE Healthcare
  33. Hillhouse Capital
  34. Illumina Ventures
  35. IncellDx
  36. Luminex (acquired by DiaSorin)
  37. LYFE Capital
  38. Merck
  39. MilliporeSigma
  40. Milkotronic
  41. Miltenyi Biotec
  42. Molecular Devices (acquired by Maureen Data Systems)
  43. NanoCellect Biomedical
  44. National Institutes of Health
  45. Nexcelom Bioscience (a subsidiary of PerkinElmer)
  46. Northern Light Venture Capital
  47. OrbiMed
  48. PerkinElmer
  49. Phitonex (acquired by Thermo Fisher Scientific)
  50. Polaris Biology
  51. Premas Life Sciences
  52. RA Capital
  53. SAGIAN Equity
  54. Sartorius
  55. Sony Biotechnology
  56. Stratedigm
  57. Sun Mountain Capital
  58. Sysmex 
  59. Thermo Fisher Scientific
  60. ThinkCyte
  61. Thorlabs
  62. Tramway Venture Partners
  63. Union Biometrica
  64. Vala Sciences 
  65. Vertical Venture Partners
  66. Virginia Venture Partners (a subsidiary of VIPC)
  67. Warburg Pincus
  68. Yokogawa 
  69. Yonjin Capital (also known as Yonjin Venture)
  70. Qiagen

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com